At a Glance
Dosage
oral
| Level | AL-LAD | 1cP-MiPLA |
|---|---|---|
| Threshold | 20 µg | 50 µg |
| Light | 50–100 µg | 100–150 µg |
| Common | 100–225 µg | 150–200 µg |
| Strong | 225–350 µg | 200–250 µg |
| Heavy | 350 µg | 300 µg |
Duration
oral
AL-LAD
oral
Total: 7 hrs – 10 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up30 min – 1 hrs
Peak2.5 hrs – 5 hrs
Effects
Safety
Interaction: AL-LAD + 1cP-MiPLA
No direct interaction data available between these substances. This does not mean the combination is safe.
AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
1cP-MiPLA — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between AL-LAD and 1cP-MiPLA?
AL-LAD is classified as a Psychedelic (Lysergamides) while 1cP-MiPLA is classified as a Psychedelic (Lysergamides). They share 67 effects in common, with 9 effects unique to AL-LAD and 3 unique to 1cP-MiPLA.
Is it safe to combine AL-LAD and 1cP-MiPLA?
There is no direct interaction data available for combining AL-LAD and 1cP-MiPLA. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, AL-LAD or 1cP-MiPLA?
At common doses via oral, AL-LAD is typically dosed at 100–225 µg while 1cP-MiPLA is dosed at 150–200 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.